New evidence for secondary axonal degeneration in demyelinating neuropathies
Tài liệu tham khảo
Abe, 2010, Compound heterozygous PMP22 deletion mutations causing severe Charcot-Marie-Tooth disease type 1, J. Hum. Genet., 55, 771, 10.1038/jhg.2010.106
Abe, 2009, Neurofilament light chain polypeptide gene mutations in Charcot-Marie-Tooth disease: nonsense mutation probably causes a recessive phenotype, J. Hum. Genet., 54, 94, 10.1038/jhg.2008.13
Abe, 1997, Pressure palsy as the initial presentation in a case of late-onset Charcot-Marie-Tooth disease type 1A, Intern. Med., 36, 501, 10.2169/internalmedicine.36.501
Adebola, 2015, Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot-Marie-Tooth Type 2E phenotype, Hum. Mol. Genet., 24, 2163, 10.1093/hmg/ddu736
Adlkofer, 1997, Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy, J. Neurosci., 17, 4662, 10.1523/JNEUROSCI.17-12-04662.1997
Adlkofer, 1995, Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice, Nat. Genet., 11, 274, 10.1038/ng1195-274
Agrawal, 2014, Expanding the phenotype associated with the NEFL mutation: neuromuscular disease in a family with overlapping myopathic and neurogenic findings, JAMA Neurol., 71, 1413, 10.1001/jamaneurol.2014.1432
Al-Shekhlee, 2005, New criteria for early electrodiagnosis of acute inflammatory demyelinating polyneuropathy, Muscle Nerve, 32, 66, 10.1002/mus.20342
Al-Thihli, 2008, Compound heterozygous deletions of PMP22 causing severe Charcot-Marie-Tooth disease of the Dejerine-Sottas disease phenotype, Am. J. Med. Genet. A, 146A, 2412, 10.1002/ajmg.a.32456
Albers, 1985, Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy, Muscle Nerve, 8, 528, 10.1002/mus.880080609
Amato, 1996, Hereditary neuropathy with liability to pressure palsies: assocation with central nervous system demyelination, Muscle Nerve, 19, 770, 10.1002/(SICI)1097-4598(199606)19:6<770::AID-MUS13>3.0.CO;2-P
Amato, 1996, Tomaculous neuropathy: a clinical and electrophysiological study in patients with and without 1.5-Mb deletions in chromosome 17p11.2, Muscle Nerve, 19, 16, 10.1002/(SICI)1097-4598(199601)19:1<16::AID-MUS3>3.0.CO;2-B
Anand, 2010, X-linked hereditary motor sensory neuropathy (type 1) presenting with a stroke-like episode, Dev. Med. Child Neurol., 52, 677, 10.1111/j.1469-8749.2010.03674.x
Andersson, 2000, Electrodiagnostic features of hereditary neuropathy with liability to pressure palsies, Neurology, 54, 40, 10.1212/WNL.54.1.40
Anzini, 1997, Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32, J. Neurosci., 17, 4545, 10.1523/JNEUROSCI.17-12-04545.1997
Appu, 2014, Novel familial pathogenic mutation in gap junction protein, beta-1 gene (GJB1) associated with transient neurological deficits in a patient with X-linked Charcot-Marie-Tooth disease, Muscle Nerve, 50, 1023, 10.1002/mus.24343
Asahina, 2000, Respiratory insufficiency in a patient with hereditary neuropathy with liability to pressure palsy, J Neurol Neurosurg Psychiatry, 68, 110, 10.1136/jnnp.68.1.110
Attarian, 2020, Hereditary neuropathy with liability to pressure palsies, J. Neurol., 267, 2198, 10.1007/s00415-019-09319-8
Auer-Grumbach, 2003, Late onset Charcot-Marie-Tooth 2 syndrome caused by two novel mutations in the MPZ gene, Neurology, 61, 1435, 10.1212/01.WNL.0000094197.46109.75
Auer-Grumbach, 2000, Clinical predominance of proximal upper limb weakness in CMT1A syndrome, Muscle Nerve, 23, 1243, 10.1002/1097-4598(200008)23:8<1243::AID-MUS13>3.0.CO;2-Z
Azulay, 1992, [Chronic polyradiculoneuritis. 25 cases], Rev Neurol (Paris), 148, 752
Babetto, 2020, A glycolytic shift in Schwann cells supports injured axons, Nat. Neurosci., 10.1038/s41593-020-0689-4
Baets, 2011, Genetic spectrum of hereditary neuropathies with onset in the first year of life, Brain, 134, 2664, 10.1093/brain/awr184
Bahr, 1999, Central visual, acoustic, and motor pathway involvement in a Charcot-Marie-Tooth family with an Asn205Ser mutation in the connexin 32 gene, J Neurol Neurosurg Psychiatry, 66, 202, 10.1136/jnnp.66.2.202
Bai, 2006, Effect of an R69C mutation in the myelin protein zero gene on myelination and ion channel subtypes, Arch. Neurol., 63, 1787, 10.1001/archneur.63.12.1787
Baker, 2008, Novel 95G&A (R32K) somatic mosaic connexin 32 mutation, Muscle Nerve, 38, 1510, 10.1002/mus.21145
Baloh, 2009, Congenital hypomyelinating neuropathy with lethal conduction failure in mice carrying the Egr2 I268N mutation, J. Neurosci., 29, 2312, 10.1523/JNEUROSCI.2168-08.2009
Banchs, 2010, Charcot-Marie-Tooth disease with intermediate conduction velocities caused by a novel mutation in the MPZ gene, Muscle Nerve, 42, 184, 10.1002/mus.21643
Barohn, 1989, Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria, Arch. Neurol., 46, 878, 10.1001/archneur.1989.00520440064022
Bayrak, 2009, Hereditary neuropathy with liability to pressure palsy (HNPP) in childhood: a case study emphasizing the relevance of detailed electrophysiological examination for suspected HNPP in the first decade, Brain Dev., 31, 445, 10.1016/j.braindev.2008.07.002
Beauvais, 2006, Clinical, electrophysiological and molecular genetic studies in a family with X-linked dominant Charcot-Marie-Tooth neuropathy presenting a novel mutation in GJB1 Promoter and a rare polymorphism in LITAF/SIMPLE, Neuromuscul. Disord., 16, 14, 10.1016/j.nmd.2005.09.008
Beirowski, 2013, Concepts for regulation of axon integrity by enwrapping glia, Front. Cell. Neurosci., 7, 256, 10.3389/fncel.2013.00256
Bellone, 2006, An abnormal mRNA produced by a novel PMP22 splice site mutation associated with HNPP, J Neurol Neurosurg Psychiatry, 77, 538, 10.1136/jnnp.2005.075242
Benedetti, 2010, Analyzing histopathological features of rare charcot-marie-tooth neuropathies to unravel their pathogenesis, Arch. Neurol., 67, 1498, 10.1001/archneurol.2010.303
Berciano, 1993, Axonal form of Guillain-Barre syndrome: evidence for macrophage-associated demyelination, Muscle Nerve, 16, 744, 10.1002/mus.880160709
Berciano, 2006, Charcot-Marie-Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study, J Neurol Neurosurg Psychiatry, 77, 1169, 10.1136/jnnp.2006.093443
Berciano, 2000, Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with charcot-marie-tooth disease 1A duplication, Neuromuscul. Disord., 10, 419, 10.1016/S0960-8966(99)00114-5
Berciano, 2000, Perineurium contributes to axonal damage in acute inflammatory demyelinating polyneuropathy, Neurology, 55, 552, 10.1212/WNL.55.4.552
Beydoun, 2013, Hereditary neuropathy with liability to pressure palsy: two cases of difficult diagnosis, J. Clin. Neuromuscul. Dis., 15, 28, 10.1097/CND.0b013e31829e22fe
Beydoun, 2008, Hereditary neuropathy with liability to pressure palsies: description of seven patients without known family history, Acta Neurol. Scand., 117, 266, 10.1111/j.1600-0404.2007.00935.x
Bienfait, 2006, Late onset axonal Charcot-Marie-Tooth phenotype caused by a novel myelin protein zero mutation, J Neurol Neurosurg Psychiatry, 77, 534, 10.1136/jnnp.2005.073437
Bird, 1997, Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: a 20-year study, Ann. Neurol., 41, 463, 10.1002/ana.410410409
Birouk, 1997, Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases, Brain, 120, 813, 10.1093/brain/120.5.813
Birouk, 1998, X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: clinical and electrophysiologic study, Neurology, 50, 1074, 10.1212/WNL.50.4.1074
Bissar-Tadmouri, 2000, Mutational analysis and genotype/phenotype correlation in Turkish Charcot-Marie-Tooth Type 1 and HNPP patients, Clin. Genet., 58, 396, 10.1034/j.1399-0004.2000.580511.x
Boerkoel, 2002, Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation, Ann. Neurol., 51, 190, 10.1002/ana.10089
Bolger, 2019, Anesthetic considerations of hereditary neuropathy with liability to pressure palsies in an obstetric patient: a case report, A A Pract, 13, 126, 10.1213/XAA.0000000000001010
Borgulova, 2013, Mosaicism for GJB1 mutation causes milder Charcot-Marie-Tooth X1 phenotype in a heterozygous man than in a manifesting heterozygous woman, Neurogenetics, 14, 189, 10.1007/s10048-013-0368-7
Bortolozzi, 2018, What’s the function of connexin 32 in the peripheral nervous system?, Front. Mol. Neurosci., 11, 227, 10.3389/fnmol.2018.00227
Boucanova, 2020, Metabolic interaction between schwann cells and axons under physiological and disease conditions, Front. Cell. Neurosci., 14, 148, 10.3389/fncel.2020.00148
Bouchard, 1999, Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy, Neurology, 52, 498, 10.1212/WNL.52.3.498
Braathen, 2010, Two novel missense mutations in the myelin protein zero gene causes Charcot-Marie-Tooth type 2 and Dejerine-Sottas syndrome, BMC Res. Notes, 3, 99, 10.1186/1756-0500-3-99
Brennan, 2015, Demyelinating CMT--what’s known, what’s new and what’s in store?, Neurosci. Lett., 596, 14, 10.1016/j.neulet.2015.01.059
Briani, 2008, Axonal neuropathy due to myelin protein zero mutation misdiagnosed as amyloid neuropathy, Muscle Nerve, 38, 921, 10.1002/mus.21062
Briani, 2010, Adult onset Charcot-Marie-Tooth disease type 1D with an Arg381Cys mutation of EGR2, Muscle Nerve, 41, 888, 10.1002/mus.21663
Bromberg, 1993, Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disorders, Muscle Nerve, 16, 262, 10.1002/mus.880160304
Brozkova, 2010, Clinical and in silico evidence for and against pathogenicity of 11 new mutations in the MPZ gene, Clin. Genet., 78, 81, 10.1111/j.1399-0004.2010.01423.x
Brozkova, 2010, Six new gap junction beta 1 gene mutations and their phenotypic expression in Czech patients with Charcot-Marie-Tooth disease, Genet. Test. Mol. Biomarkers, 14, 3, 10.1089/gtmb.2009.0093
Brugger, 2015, HDAC1/2-dependent P0 expression maintains paranodal and nodal integrity independently of myelin stability through interactions with neurofascins, PLoS Biol., 13, 10.1371/journal.pbio.1002258
Bulusu, 2011, A report of hereditary neuropathy with liability to pressure palsy (HNPP) presenting with brachial plexopathy: the value of complete electrodiagnostic testing, Am. J. Electroneurodiagnostic Technol., 51, 183, 10.1080/1086508X.2011.11079818
Capponi, 2015, Contribution of copy number variations in CMT1X: a retrospective study, Eur. J. Neurol., 22, 406, 10.1111/ene.12434
Carpenter, 1972, An ultrastructural study of an acute fatal case of the Guillain-Barre syndrome, J. Neurol. Sci., 15, 125, 10.1016/0022-510X(72)90001-9
Carvalho, 2005, Charcot-Marie-Tooth disease type 1A: clinicopathological correlations in 24 patients, J. Peripher. Nerv. Syst., 10, 85, 10.1111/j.1085-9489.2005.10112.x
Casasnovas, 2012, A novel small deletion in PMP22 causes a mild hereditary neuropathy with liability to pressure palsies phenotype, Muscle Nerve, 45, 135, 10.1002/mus.22201
Cea, 2019, Wrist drop in an arcade dancing game: unusual sudden bilateral radial palsy, Neuromuscul. Disord., 29, 398, 10.1016/j.nmd.2019.02.005
Chanson, 2014, Early electrodiagnostic abnormalities in acute inflammatory demyelinating polyneuropathy: a retrospective study of 58 patients, Clin. Neurophysiol., 125, 1900, 10.1016/j.clinph.2014.01.007
Chapon, 1999, Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene, J Neurol Neurosurg Psychiatry, 66, 779, 10.1136/jnnp.66.6.779
Chavada, 2012, A novel MPZ gene mutation in exon 2 causing late-onset demyelinating Charcot-Marie-Tooth disease, J. Clin. Neuromuscul. Dis., 13, 206, 10.1097/CND.0b013e3182461a83
Chen, 2019, Genetic spectrum and clinical profiles in a southeast Chinese cohort of Charcot-Marie-Tooth disease, Clin. Genet., 96, 439, 10.1111/cge.13616
Chen, 2018, An 8-generation family with X-linked Charcot-Marie-Tooth: confirmation of the pathogenicity of a 3’ untranslated region mutation in GJB1 and its clinical features, Muscle Nerve, 57, 859, 10.1002/mus.26037
Chen, 2011, A novel mutation of gap junction protein beta 1 gene in X-linked Charcot-Marie-Tooth disease, Muscle Nerve, 43, 887, 10.1002/mus.21992
Chin, 2013, SIMPLE: A new regulator of endosomal trafficking and signaling in health and disease, Commun. Integr. Biol., 6, 10.4161/cib.24214
Chiu, 2011, Matching mitochondria to metabolic needs at nodes of Ranvier, Neuroscientist, 17, 343, 10.1177/1073858410393740
Cifuentes-Diaz, 2011, Nodes of ranvier and paranodes in chronic acquired neuropathies, PLoS One, 6, 10.1371/journal.pone.0014533
Cil, 2009, Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: a case report (vincristine-induced severe polyneuropathy), J. Pediatr. Hematol. Oncol., 31, 787, 10.1097/MPH.0b013e3181b530ad
Cisterna, 2019, Role of connexin-based gap junction channels in communication of myelin sheath in schwann cells, Front. Cell. Neurosci., 13, 69, 10.3389/fncel.2019.00069
Coleman, 2020, Programmed axon degeneration: from mouse to mechanism to medicine, Nat. Rev. Neurosci., 21, 183, 10.1038/s41583-020-0269-3
Conforti, 2014, Wallerian degeneration: an emerging axon death pathway linking injury and disease, Nat. Rev. Neurosci., 15, 394, 10.1038/nrn3680
Cortese, 2020, Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: clinical relevance of IgG isotype, Neurol. Neuroimmunol. Neuroinflamm., 7, 10.1212/NXI.0000000000000639
Crum, 2000, Fulminant case of hereditary neuropathy with liability to pressure palsy, Muscle Nerve, 23, 979, 10.1002/(SICI)1097-4598(200006)23:6<979::AID-MUS23>3.0.CO;2-0
Cruz-Martinez, 1998, Pediatric bilateral carpal tunnel syndrome as first manifestation of hereditary neuropathy with liability to pressure palsies (HNPP), Eur. J. Neurol., 5, 316, 10.1046/j.1468-1331.1998.530316.x
Cruz-Martinez, 2000, Peroneal neuropathy after weight loss, J. Peripher. Nerv. Syst., 5, 101, 10.1046/j.1529-8027.2000.00007.x
Cruz-Martinez, 1997, Hereditary neuropathy with liability to pressure palsies (HNPP) revealed after weight loss, Eur. Neurol., 37, 257, 10.1159/000117463
D’Arrigo, 2020, A case of severe early-onset neuropathy caused by a compound heterozygous deletion of the PMP22 gene: clinical and neurographic aspects, Neuropediatrics, 51, 173, 10.1055/s-0039-3400985
Dacci, 2012, Myelin protein zero Arg36Gly mutation with very late onset and rapidly progressive painful neuropathy, J. Peripher. Nerv. Syst., 17, 422, 10.1111/j.1529-8027.2012.00443.x
Dalkara, 1990, Acute idiopathic demyelinating polyneuropathy: passive transfer to mice by immunoglobulin, Neuroreport, 1, 145, 10.1097/00001756-199010000-00016
De Angelis, 2004, Segmental conduction abnormalities and myelin thickenings in Val102/fs null mutation of MPZ gene, Neurology, 63, 2180, 10.1212/01.WNL.0000145707.17402.1D
De Jonghe, 2001, Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E, Ann. Neurol., 49, 245, 10.1002/1531-8249(20010201)49:2<245::AID-ANA45>3.0.CO;2-A
De Jonghe, 1999, The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype, Brain, 122, 281, 10.1093/brain/122.2.281
de Oliveira, 2016, Clinical and neurophysiological features of the hereditary neuropathy with liability to pressure palsy due to the 17p11.2 deletion, Arq. Neuropsiquiatr., 74, 99, 10.1590/0004-282X20160010
de Vries, 2011, The phenotype of the Gly94fsX222 PMP22 insertion, J. Peripher. Nerv. Syst., 16, 113, 10.1111/j.1529-8027.2011.00333.x
de Waegh, 1990, Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions, J. Neurosci., 10, 1855, 10.1523/JNEUROSCI.10-06-01855.1990
de Waegh, 1991, Local control of axonal properties by Schwann cells: neurofilaments and axonal transport in homologous and heterologous nerve grafts, J. Neurosci. Res., 30, 201, 10.1002/jnr.490300121
Debruyne, 1980, Hereditary pressure-sensitive neuropathy, J. Neurol. Sci., 47, 385, 10.1016/0022-510X(80)90091-X
Delanoe, 1998, Acute inflammatory demyelinating polyradiculopathy in children: clinical and electrodiagnostic studies, Ann. Neurol., 44, 350, 10.1002/ana.410440310
Delmont, 2020, Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera, J. Neurol., 10.1007/s00415-020-10041-z
Dequen, 2010, Reversal of neuropathy phenotypes in conditional mouse model of Charcot-Marie-Tooth disease type 2E, Hum. Mol. Genet., 19, 2616, 10.1093/hmg/ddq149
Devaux, 2005, Altered ion channels in an animal model of Charcot-Marie-Tooth disease type IA, J. Neurosci., 25, 1470, 10.1523/JNEUROSCI.3328-04.2005
Deymeer, 2011, Nerve conduction studies in Charcot-Marie-Tooth disease in a cohort from Turkey, Muscle Nerve, 43, 657, 10.1002/mus.21932
Donaghy, 2000, Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation, J Neurol Neurosurg Psychiatry, 69, 799, 10.1136/jnnp.69.6.799
Doppler, 2016, Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy, Brain, 139, 2617, 10.1093/brain/aww189
Doppler, 2015, Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies, J Neurol Neurosurg Psychiatry, 86, 720, 10.1136/jnnp-2014-309916
Doppler, 2017, Painful Charcot-Marie-Tooth neuropathy type 2E/1F due to a novel NEFL mutation, Muscle Nerve, 55, 752, 10.1002/mus.25410
Duan, 2016, A novel Asp121Asn mutation of myelin protein zero is associated with late-onset axonal charcot-marie-Tooth disease, hearing loss and pupil abnormalities, Front. Aging Neurosci., 8, 222, 10.3389/fnagi.2016.00222
Dupre, 1999, Clinical and electrophysiological study in French-Canadian population with Charcot-Marie-tooth disease type 1A associated with 17p11.2 duplication, Can. J. Neurol. Sci., 26, 196, 10.1017/S031716710000024X
Dupre, 2001, A founder mutation in French-Canadian families with X-linked hereditary neuropathy, Can. J. Neurol. Sci., 28, 51, 10.1017/S0317167100052550
Eggers, 2004, Clinical and genetic description of a family with Charcot-Marie-Tooth disease type 1B from a transmembrane MPZ mutation, Muscle Nerve, 29, 867, 10.1002/mus.20034
Elbracht, 2014, Clinical and morphological variability of the E396K mutation in the neurofilament light chain gene in patients with Charcot-Marie- Tooth disease type 2E, Clin. Neuropathol., 33, 335, 10.5414/NP300742
Fabrizi, 2004, Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E, Neurology, 62, 1429, 10.1212/01.WNL.0000120664.07186.3C
Fabrizi, 2007, Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton, Brain, 130, 394, 10.1093/brain/awl284
Fabrizi, 1999, Novel mutation of the P0 extracellular domain causes a Dejerine-Sottas syndrome, J Neurol Neurosurg Psychiatry, 66, 386, 10.1136/jnnp.66.3.386
Fabrizi, 1998, Clinical and pathological correlations in Charcot-Marie-Tooth neuropathy type 1A with the 17p11.2p12 duplication: a cross-sectional morphometric and immunohistochemical study in twenty cases, Muscle Nerve, 21, 869, 10.1002/(SICI)1097-4598(199807)21:7<869::AID-MUS4>3.0.CO;2-4
Fabrizi, 2001, PMP22 related congenital hypomyelination neuropathy, J Neurol Neurosurg Psychiatry, 70, 123, 10.1136/jnnp.70.1.123
Farrar, 2014, Axonal dysfunction, dysmyelination, and conduction failure in hereditary neuropathy with liability to pressure palsies, Muscle Nerve, 49, 858, 10.1002/mus.24085
Feng, 2020, The comparison of MRN, electrophysiology and progression among typical CIDP and atypical CIDP subtypes, Sci. Rep., 10, 16697, 10.1038/s41598-020-73104-1
Finsterer, 2006, Novel C59T leader peptide mutation in the MPZ gene associated with late-onset, axonal, sensorimotor polyneuropathy, Eur. J. Neurol., 13, 1149, 10.1111/j.1468-1331.2006.01479.x
Fledrich, 2018, Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy, Nat. Commun., 9, 3025, 10.1038/s41467-018-05420-0
Fledrich, 2019, Axo-glial interdependence in peripheral nerve development, Development, 146, 10.1242/dev.151704
Fledrich, 2012, A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients, Brain, 135, 72, 10.1093/brain/awr322
Floroskufi, 2007, New mutation of the MPZ gene in a family with the Dejerine-Sottas disease phenotype, Muscle Nerve, 35, 667, 10.1002/mus.20703
Franssen, 2019, Physiology of myelinated nerve conduction and pathophysiology of demyelination, Adv. Exp. Med. Biol., 1190, 85, 10.1007/978-981-32-9636-7_7
Frei, 1999, Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice, J. Neurosci., 19, 6058, 10.1523/JNEUROSCI.19-14-06058.1999
Fressinaud, 2011, Axon cytoskeleton ultrastructure in chronic inflammatory demyelinating polyneuropathy, Muscle Nerve, 44, 332, 10.1002/mus.22069
Friedman, 1996, A distinct pattern of trophic factor expression in myelin-deficient nerves of Trembler mice: implications for trophic support by Schwann cells, J. Neurosci., 16, 5344, 10.1523/JNEUROSCI.16-17-05344.1996
Fruttiger, 1995, Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity, Eur. J. Neurosci., 7, 511, 10.1111/j.1460-9568.1995.tb00347.x
Fu, 2018, A novel homozygous nonsense mutation in NEFL causes autosomal recessive Charcot-Marie-Tooth disease, Neuromuscul. Disord., 28, 44, 10.1016/j.nmd.2017.09.018
Funfschilling, 2012, Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity, Nature, 485, 517, 10.1038/nature11007
Gallardo, 2006, Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles, Brain, 129, 426, 10.1093/brain/awh693
Gallardo, 2009, Charcot-Marie-Tooth disease type 2J with MPZ Thr124Met mutation: clinico-electrophysiological and MRI study of a family, J. Neurol., 256, 2061, 10.1007/s00415-009-5251-y
Garcia, 1998, Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study, Neurology, 50, 1061, 10.1212/WNL.50.4.1061
Garcia-Santibanez, 2015, Rapid improvement of hereditary neuropathy with liability to pressure palsies following cubital tunnel release, Muscle Nerve, 52, 910, 10.1002/mus.24762
Gargaun, 2016, EGR2 mutation enhances phenotype spectrum of Dejerine-Sottas syndrome, J. Neurol., 263, 1456, 10.1007/s00415-016-8153-9
Geden, 2016, Axon degeneration: context defines distinct pathways, Curr. Opin. Neurobiol., 39, 108, 10.1016/j.conb.2016.05.002
Gess, 2011, Report of a novel mutation in the PMP22 gene causing an axonal neuropathy, Muscle Nerve, 43, 605, 10.1002/mus.21973
Ginanneschi, 2012, Sonographic and electrodiagnostic features of hereditary neuropathy with liability to pressure palsies, J. Peripher. Nerv. Syst., 17, 391, 10.1111/j.1529-8027.2012.00437.x
Gochard, 2007, Bilateral hand amyotrophy with PMP-22 gene deletion, Eur. J. Neurol., 14, 115, 10.1111/j.1468-1331.2006.01576.x
Goodfellow, 2016, Antiganglioside, antiganglioside-complex, and antiglycolipid-complex antibodies in immune-mediated neuropathies, Curr. Opin. Neurol., 29, 572, 10.1097/WCO.0000000000000361
Gorson, 1997, Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy, Neurology, 48, 321, 10.1212/WNL.48.2.321
Gouider, 1995, Clinical, electrophysiologic, and molecular correlations in 13 families with hereditary neuropathy with liability to pressure palsies and a chromosome 17p11.2 deletion, Neurology, 45, 2018, 10.1212/WNL.45.11.2018
Gouvea, 2019, New novel mutations in Brazilian families with X-linked Charcot-Marie-Tooth disease, J. Peripher. Nerv. Syst., 24, 207, 10.1111/jns.12327
Graf, 1996, Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A, Cancer, 77, 1356, 10.1002/(SICI)1097-0142(19960401)77:7<1356::AID-CNCR20>3.0.CO;2-#
Grandis, 2004, Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease, Exp. Neurol., 190, 213, 10.1016/j.expneurol.2004.07.008
Grossman, 2007, Hereditary neuropathy with liability to pressure palsies: case report and discussion, HSS J., 3, 208, 10.1007/s11420-007-9056-1
Grosz, 2019, A de novo EGR2 variant, c.1232A & G p.Asp411Gly, causes severe early-onset Charcot-Marie-Tooth Neuropathy Type 3 (Dejerine-Sottas Neuropathy), Sci. Rep., 9, 19336, 10.1038/s41598-019-55875-4
Guimaraes-Costa, 2017, Phenotypic spectrum of Charcot-Marie-Tooth disease due to LITAF/SIMPLE mutations: a study of 18 patients, Eur. J. Neurol., 24, 530, 10.1111/ene.13239
Guo, 2010, Mutation in connexin 32 causes Charcot-Marie-Tooth disease in a large Chinese family, Muscle Nerve, 42, 715, 10.1002/mus.21756
Guo, 2014, Abnormal junctions and permeability of myelin in PMP22-deficient nerves, Ann. Neurol., 75, 255, 10.1002/ana.24086
Guo, 2014, Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy, J. Clin. Neurosci., 21, 587, 10.1016/j.jocn.2013.05.023
Gutierrez, 2000, Unusual electrophysiological findings in X-linked dominant Charcot-Marie-Tooth disease, Muscle Nerve, 23, 182, 10.1002/(SICI)1097-4598(200002)23:2<182::AID-MUS6>3.0.CO;2-W
Hafer-Macko, 1996, Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy, Ann. Neurol., 39, 625, 10.1002/ana.410390512
Hahn, 1999, Genotype/Phenotype correlations in X-Linked dominant charcot-marie-Tooth disease, Ann. N. Y. Acad. Sci., 883, 366, 10.1111/j.1749-6632.1999.tb08598.x
Hahn, 1990, X-linked dominant hereditary motor and sensory neuropathy, Brain, 113, 1511, 10.1093/brain/113.5.1511
Hanemann, 2001, Axon damage in CMT due to mutation in myelin protein P0, Neuromuscul. Disord., 11, 753, 10.1016/S0960-8966(01)00229-2
Haq, 2000, Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria, Arch. Neurol., 57, 1745, 10.1001/archneur.57.12.1745
Harada, 2016, Hereditary neuropathy with liability to pressure palsies: diverse phenotypes in childhood, J. Clin. Neuromuscul. Dis., 18, 79, 10.1097/CND.0000000000000136
Harbo, 2008, Length-dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy, Muscle Nerve, 38, 1036, 10.1002/mus.21000
Hardy, 2019, X-linked charcot-marie-Tooth disease presenting with stuttering stroke-like symptoms, Neuropediatrics, 50, 304, 10.1055/s-0039-1692982
Hashiguchi, 2014, Neurofilament light mutation causes hereditary motor and sensory neuropathy with pyramidal signs, J. Peripher. Nerv. Syst., 19, 311, 10.1111/jns.12102
Hattori, 2003, Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients, Brain, 126, 134, 10.1093/brain/awg012
He, 2018, Clinical and genetic investigation in Chinese patients with demyelinating Charcot-Marie-Tooth disease, J. Peripher. Nerv. Syst., 23, 216, 10.1111/jns.12277
He, 2012, Hereditary neuropathy with liability to pressure palsy: an investigation in a rare and large Chinese family, Eur. Neurol., 68, 322, 10.1159/000341836
Heckmann, 2007, Hereditary neuropathy with liability to pressure palsy combined with schwannomas of the median and medial plantar nerves, Muscle Nerve, 35, 122, 10.1002/mus.20641
Heininger, 1986, Conduction failure and nerve conduction slowing in experimental allergic neuritis induced by P2-specific T-cell lines, Ann. Neurol., 19, 44, 10.1002/ana.410190109
Heng, 2012, Beneficial use of steroids in hereditary neuropathy with liability to pressure palsy, Dev. Med. Child Neurol., 54, 183, 10.1111/j.1469-8749.2011.04131.x
Henry, 1983, Comparison of Trembler and Trembler-J mouse phenotypes: varying severity of peripheral hypomyelination, J. Neuropathol. Exp. Neurol., 42, 688, 10.1097/00005072-198311000-00008
Hong, 2017, Clinical characterization and genetic analysis of Korean patients with X-linked Charcot-Marie-Tooth disease type 1, J. Peripher. Nerv. Syst., 22, 172, 10.1111/jns.12217
Hong, 2003, Clinical and electrophysiologic features of HNPP patients with 17p11.2 deletion, Acta Neurol. Scand., 108, 352, 10.1034/j.1600-0404.2003.00132.x
Hoogendijk, 1994, Hereditary motor and sensory neuropathy type I: clinical and neurographical features of the 17p duplication subtype, Muscle Nerve, 17, 85, 10.1002/mus.880170112
Horga, 2017, Genetic and clinical characteristics of NEFL-related Charcot-Marie-Tooth disease, J Neurol Neurosurg Psychiatry, 88, 575, 10.1136/jnnp-2016-315077
Horowitz, 2004, Hereditary neuropathy with liability to pressure palsy: fulminant development with axonal loss during military training, J Neurol Neurosurg Psychiatry, 75, 1629, 10.1136/jnnp.2003.029314
Hosokawa, 2014, An electrophysiological classification associated with Guillain-Barre syndrome outcomes, J. Neurol., 261, 1986, 10.1007/s00415-014-7452-2
Hu, 2016, Tuning PAK activity to rescue abnormal myelin permeability in HNPP, PLoS Genet., 12, 10.1371/journal.pgen.1006290
Hu, 2019, Novel gap junction protein beta-1 gene mutation associated with a stroke-like syndrome and central nervous system involvement in patients with X-linked Charcot-Marie-Tooth Type 1: a case report and literature review, Clin. Neurol. Neurosurg., 180, 68, 10.1016/j.clineuro.2019.03.018
Iida, 2012, A novel MPZ mutation in Charcot-Marie-Tooth disease type 1B with focally folded myelin and multiple entrapment neuropathies, Neuromuscul. Disord., 22, 166, 10.1016/j.nmd.2011.08.005
Ikeda, 2019, Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy, J Neurol Neurosurg Psychiatry, 90, 988, 10.1136/jnnp-2019-320741
Infante, 2001, Diagnostic strategy for familial and sporadic cases of neuropathy associated with 17p11.2 deletion, Muscle Nerve, 24, 1149, 10.1002/mus.1126
Ionasescu, 1997, Dejerine-Sottas neuropathy in mother and son with same point mutation of PMP22 gene, Muscle Nerve, 20, 97, 10.1002/(SICI)1097-4598(199701)20:1<97::AID-MUS13>3.0.CO;2-Z
Isaacs, 2002, Identification of a new Pmp22 mouse mutant and trafficking analysis of a Pmp22 allelic series suggesting that protein aggregates may be protective in Pmp22-associated peripheral neuropathy, Mol. Cell. Neurosci., 21, 114, 10.1006/mcne.2002.1158
Ishaque, 2015, Guillain-Barre syndrome (demyelinating) six weeks after bariatric surgery: a case report and literature review, Obes. Res. Clin. Pract., 9, 416, 10.1016/j.orcp.2015.02.001
Jankelowitz, 2013, Pathophysiology of HNPP explored using axonal excitability, J. Neurol. Neurosurg. Psychiatry, 84, 806, 10.1136/jnnp-2012-304576
Jerath, 2015, Coexistence of a T118M PMP22 missense mutation and chromosome 17 (17p11.2-p12) deletion, Muscle Nerve, 52, 905, 10.1002/mus.24713
Jerath, 2017, Charcot-Marie-Tooth disease type 1C: clinical and electrophysiological findings for the c.334G&a (p.Gly112Ser) Litaf/Simple mutation, Muscle Nerve, 56, 1092, 10.1002/mus.25600
Jiao, 2018, The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain-Barre syndrome, Drug Des. Devel. Ther., 12, 3817, 10.2147/DDDT.S175331
Joo, 2004, A novel point mutation in PMP22 gene associated with a familial case of Charcot-Marie-Tooth disease type 1A with sensorineural deafness, Neuromuscul. Disord., 14, 325, 10.1016/j.nmd.2004.02.009
Jordanova, 2003, Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease, Brain, 126, 590, 10.1093/brain/awg059
Jouaud, 2016, Congenital hypomyelinating neuropathy due to the association of a truncating mutation in PMP22 with the classical HNPP deletion, Neuromuscul. Disord., 26, 316, 10.1016/j.nmd.2016.01.004
Juneja, 2019, Challenges in modelling the Charcot-Marie-Tooth neuropathies for therapy development, J Neurol Neurosurg Psychiatry, 90, 58, 10.1136/jnnp-2018-318834
Jung, 2004, Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization, J. Neurosci. Res., 75, 524, 10.1002/jnr.10879
Kabzinska, 2007, Late-onset Charcot-Marie-Tooth type 2 disease with hearing impairment associated with a novel Pro105Thr mutation in the MPZ gene, Am. J. Med. Genet. A, 143A, 2196, 10.1002/ajmg.a.31908
Kabzinska, 2010, Charcot-Marie-Tooth type 1A disease caused by a novel Ser112Arg mutation in the PMP22 gene, coexisting with a slowly progressive hearing impairment, J. Appl. Genet., 51, 203, 10.1007/BF03195729
Kalfakis, 2002, Hereditary neuropathy with liability to pressure palsies emerging during vincristine treatment, Neurology, 59, 1470, 10.1212/01.WNL.0000032505.45389.94
Kanda, 1989, A fulminant case of Guillain-Barre syndrome: topographic and fibre size related analysis of demyelinating changes, J Neurol Neurosurg Psychiatry, 52, 857, 10.1136/jnnp.52.7.857
Kanda, 2004, Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1, J Neurol Neurosurg Psychiatry, 75, 765, 10.1136/jnnp.2003.025692
Karadima, 2004, A V38A mutation in X-linked Charcot-Marie-Tooth neuropathy with unusual clinical features, J. Neurol., 251, 222, 10.1007/s00415-004-0284-8
Karadimas, 1999, Three novel mutations in the gap junction beta 1 (GJB1) gene coding region identified in Charcot-Marie-Tooth patients of Greek origin: T55I, R164Q, V120E. Mutation in brief no 236, Online, Hum Mutat, 13, 339, 10.1002/(SICI)1098-1004(1999)13:4<339::AID-HUMU18>3.0.CO;2-S
Kawaguchi, 2012, Two cases of elderly-onset hereditary neuropathy with liability to pressure palsy manifesting bilateral peroneal nerve palsies, Case Rep. Neurol., 4, 149, 10.1159/000342132
Keckarevic-Markovic, 2009, Mutational analysis of GJB1, MPZ, PMP22, EGR2, and LITAF/SIMPLE in serbian charcot-marie-Tooth patients, J. Peripher. Nerv. Syst., 14, 125, 10.1111/j.1529-8027.2009.00222.x
Khiani, 2008, Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection, World J. Gastroenterol., 14, 318, 10.3748/wjg.14.318
Kilfoyle, 2006, Myelin protein zero mutation His39Pro: hereditary motor and sensory neuropathy with variable onset, hearing loss, restless legs and multiple sclerosis, J Neurol Neurosurg Psychiatry, 77, 963, 10.1136/jnnp.2006.090076
Kim, 2014, Sonographic evaluation of the peripheral nerves in hereditary neuropathy with liability to pressure palsies: a case report, Ann. Rehabil. Med., 38, 109, 10.5535/arm.2014.38.1.109
Kim, 2004, Hereditary neuropathy with liability to pressure palsies (HNPP) patients of Korean ancestry with chromosome 17p11.2-p12 deletion, Exp. Mol. Med., 36, 28, 10.1038/emm.2004.4
Kim, 2012, Comparison between clinical disabilities and electrophysiological values in Charcot-Marie-Tooth 1A patients with PMP22 duplication, J. Clin. Neurol., 8, 139, 10.3988/jcn.2012.8.2.139
Kimber, 2003, Pathological findings in a patient with ventilatory failure and chronic inflammatory demyelinating polyneuropathy, J. Peripher. Nerv. Syst., 8, 13, 10.1046/j.1529-8027.2003.03003.x
Kirkpatrick, 1994, Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells, J. Neurosci., 14, 7440, 10.1523/JNEUROSCI.14-12-07440.1994
Kiryu-Seo, 2010, Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport, J. Neurosci., 30, 6658, 10.1523/JNEUROSCI.5265-09.2010
Kleopa, 2012, How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease?, Brain Res., 1487, 198, 10.1016/j.brainres.2012.03.068
Kleopa, 2006, Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X, Neurology, 66, 396, 10.1212/01.wnl.0000196479.93722.59
Kobsar, 2005, Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A, J. Neurosci. Res., 81, 857, 10.1002/jnr.20601
Kochanski, 2003, Focally folded myelin in Charcot-Marie-Tooth type 1B disease is associated with Asn131Lys mutation in myelin protein zero gene: short report, Eur. J. Neurol., 10, 547, 10.1046/j.1468-1331.2003.00640.x
Kochanski, 2004, A novel MPZ gene mutation in congenital neuropathy with hypomyelination, Neurology, 62, 2122, 10.1212/01.WNL.0000127606.93772.3A
Kochanski, 2004, An axonal form of Charcot-Marie-Tooth disease with a novel missense mutation in the myelin protein zero gene, J. Peripher. Nerv. Syst., 9, 1, 10.1111/j.1085-9489.2004.09101.x
Kohl, 2010, MCP-1/CCL2 modifies axon properties in a PMP22-overexpressing mouse model for Charcot-Marie-tooth 1A neuropathy, Am. J. Pathol., 176, 1390, 10.2353/ajpath.2010.090694
Koike, 2005, Age associated axonal features in HNPP with 17p11.2 deletion in Japan, J Neurol Neurosurg Psychiatry, 76, 1109, 10.1136/jnnp.2004.048140
Koike, 2017, Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies, J Neurol Neurosurg Psychiatry, 88, 465, 10.1136/jnnp-2016-314895
Komyathy, 2013, Anterior tibialis CMAP amplitude correlations with impairment in CMT1A, Muscle Nerve, 47, 493, 10.1002/mus.23614
Krajewski, 1999, Correlation between weakness and axonal loss in patients with CMT1A, Ann. N. Y. Acad. Sci., 883, 490, 10.1111/j.1749-6632.1999.tb08618.x
Krajewski, 2000, Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A, Brain, 123, 1516, 10.1093/brain/123.7.1516
Krendel, 1989, Sural nerve biopsy in chronic inflammatory demyelinating polyradiculoneuropathy, Muscle Nerve, 12, 257, 10.1002/mus.880120402
Kulkarni, 2010, Sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy: are supportive pathologic criteria useful in diagnosis?, Neurol. India, 58, 542, 10.4103/0028-3886.68673
Kulkarni, 2015, Atypical presentation of Charcot-Marie-Tooth disease 1A: a case report, Neuromuscul. Disord., 25, 916, 10.1016/j.nmd.2015.09.002
Kulshrestha, 2017, Deletion of P2 promoter of GJB1 gene a cause of Charcot-Marie-Tooth disease, Neuromuscul. Disord., 27, 766, 10.1016/j.nmd.2017.05.001
Kumar, 1999, Variability of presentation in hereditary neuropathy with liability to pressure palsy results in Underrecognition, Ann. N. Y. Acad. Sci., 883, 344, 10.1111/j.1749-6632.1999.tb08596.x
Kurihara, 2004, Charcot-Marie-Tooth families in Japan with MPZ Thr124Met mutation, J Neurol Neurosurg Psychiatry, 75, 1492, 10.1136/jnnp.2003.020107
Kurihara, 2003, Axonal and demyelinating forms of the MPZ Thr124Met mutation, Acta Neurol. Scand., 108, 157, 10.1034/j.1600-0404.2003.00110.x
Kusunoki, 2001, Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry, Neurology, 57, 736, 10.1212/WNL.57.4.736
Kuwabara, 2004, Sensory nerve conduction in demyelinating and axonal Guillain-Barre syndromes, Eur. Neurol., 51, 196, 10.1159/000078485
Lagueny, 2001, Mild recurrent neuropathy in CMT1B with a novel nonsense mutation in the extracellular domain of the MPZ gene, J Neurol Neurosurg Psychiatry, 70, 232, 10.1136/jnnp.70.2.232
Lagueny, 1999, Peripheral myelin modification in CMT1B correlates with MPZ gene mutations, Neuromuscul. Disord., 9, 361, 10.1016/S0960-8966(99)00031-0
Lau, 2019, Clinical Reasoning: A 15-year-old boy with bilateral wrist pain in the setting of weight loss, Neurology, 92, 486, 10.1212/WNL.0000000000007034
Laura, 2007, Rapid progression of late onset axonal Charcot-Marie-Tooth disease associated with a novel MPZ mutation in the extracellular domain, J Neurol Neurosurg Psychiatry, 78, 1263, 10.1136/jnnp.2006.112276
Leal, 2014, A Costa Rican family affected with Charcot-Marie-Tooth disease due to the myelin protein zero (MPZ) p.Thr124Met mutation shares the Belgian haplotype, Rev. Biol. Trop., 62, 1285, 10.15517/rbt.v62i4.13473
Lee, 2002, Six novel connexin32 (GJB1) mutations in X-linked Charcot-Marie-Tooth disease, J Neurol Neurosurg Psychiatry, 73, 304, 10.1136/jnnp.73.3.304
Lee, 2013, Motor and sensory neuropathy due to myelin infolding and paranodal damage in a transgenic mouse model of Charcot-Marie-Tooth disease type 1C, Hum. Mol. Genet., 22, 1755, 10.1093/hmg/ddt022
Lee, 2008, MPZ mutation G123S characterization: evidence for a complex pathogenesis in CMT disease, Neurology, 70, 273, 10.1212/01.wnl.0000296828.66915.bf
Lenssen, 1998, Hereditary neuropathy with liability to pressure palsies. Phenotypic differences between patients with the common deletion and a PMP22 frame shift mutation, Brain, 121, 1451, 10.1093/brain/121.8.1451
Leonardi, 2019, Widening the phenotypical spectrum of EGR2-related CMT: unusual phenotype for R409W mutation, Clin. Neurophysiol., 130, 93, 10.1016/j.clinph.2018.11.007
Lewis, 2003, Motor unit number estimate of distal and proximal muscles in Charcot-Marie-Tooth disease, Muscle Nerve, 28, 161, 10.1002/mus.10419
Li, 2017, Caveats in the established understanding of CMT1A, Ann. Clin. Transl. Neurol., 4, 601, 10.1002/acn3.432
Li, 2006, Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration, J. Comp. Neurol., 498, 252, 10.1002/cne.21051
Li, 2007, Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies, Arch. Neurol., 64, 974, 10.1001/archneur.64.7.974
Li, 2002, Hereditary neuropathy with liability to pressure palsy: the electrophysiology fits the name, Neurology, 58, 1769, 10.1212/WNL.58.12.1769
Li, 2009, -459C&T point mutation in 5’ non-coding region of human GJB1 gene is linked to X-linked Charcot-Marie-Tooth neuropathy, J. Peripher. Nerv. Syst., 14, 14, 10.1111/j.1529-8027.2009.00201.x
Li, 2010, Vocal cord paresis and probable X-linked Charcot-Marie-Tooth disease with novel GJB1 mutation, Int. J. Neurosci., 120, 731, 10.3109/00207454.2010.513461
Li, 2015, Dysregulated inflammatory signaling upon charcot-marie-Tooth type 1C mutation of SIMPLE protein, Mol. Cell. Biol., 35, 2464, 10.1128/MCB.00300-15
Liang, 2014, Axonal excitability in X-linked dominant Charcot Marie Tooth disease, Clin. Neurophysiol., 125, 1261, 10.1016/j.clinph.2013.11.004
Liang, 2005, Severe neuropathy with leaky connexin32 hemichannels, Ann. Neurol., 57, 749, 10.1002/ana.20459
Liao, 2017, Clinical and molecular characterization of PMP22 point mutations in Taiwanese patients with inherited neuropathy, Sci. Rep., 7, 15363, 10.1038/s41598-017-14771-5
Lin, 2011, The mutational spectrum in a cohort of Charcot-Marie-Tooth disease type 2 among the Han Chinese in Taiwan, PLoS One, 6, 10.1371/journal.pone.0029393
Lin, 2010, A novel deletion mutation in GJB1 causes X-linked Charcot-Marie-Tooth disease in a Han Chinese family, Muscle Nerve, 42, 922, 10.1002/mus.21790
Liu, 2013, Two novel MPZ mutations in Chinese CMT patients, J. Peripher. Nerv. Syst., 18, 256, 10.1111/jns5.12040
Liu, 2017, Phenotypes and cellular effects of GJB1 mutations causing CMT1X in a cohort of 226 Chinese CMT families, Clin. Genet., 91, 881, 10.1111/cge.12913
Liu, 2020, A novel GJB1 mutation associated with X-linked Charcot-Marie-Tooth disease in a large Chinese family pedigree, Mol. Genet. Genomic Med., 8, e1127, 10.1002/mgg3.1127
Lonigro, 2009, Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis, Brain, 132, 260, 10.1093/brain/awn281
Lopez-Verrilli, 2012, Transfer of vesicles from schwann cells to axons: a novel mechanism of communication in the peripheral nervous system, Front. Physiol., 3, 205, 10.3389/fphys.2012.00205
Lorance, 2018, Novel myelin protein zero mutation in 3 generations of vermonters with demyelinating charcot-marie-Tooth disease, J. Clin. Neuromuscul. Dis., 19, 101, 10.1097/CND.0000000000000188
Low, 1976, Hereditary hypertrophic neuropathy in the trembler mouse. Part 2. Histopathological studies: electron microscopy, J. Neurol. Sci., 30, 343, 10.1016/0022-510X(76)90139-8
Lu, 2000, Physiologic-pathologic correlation in Guillain-Barre syndrome in children, Neurology, 54, 33, 10.1212/WNL.54.1.33
Lu, 2017, Clinical and genetic features of chinese X-linked charcot-marie-Tooth type 1 disease, Chin Med J (Engl), 130, 1049, 10.4103/0366-6999.204925
Luigetti, 2008, A new single-nucleotide deletion of PMP22 in an HNPP family without recurrent palsies, Muscle Nerve, 38, 1060, 10.1002/mus.21083
Luigetti, 2011, A novel GJB1 mutation in an Italian patient with Charcot-Marie-Tooth disease and pyramidal signs, Muscle Nerve, 44, 613, 10.1002/mus.22156
Luigetti, 2010, A case of CMT 1B due to Val 102/fs null mutation of the MPZ gene presenting as hyperCKemia, Clin. Neurol. Neurosurg., 112, 794, 10.1016/j.clineuro.2010.05.001
Luigetti, 2016, Nerve ultrasound in CMT2E/CMT1F due to NEFL mutation: confirmation of an axonal pathology, Clin. Neurophysiol., 127, 2990, 10.1016/j.clinph.2016.06.024
Luigetti, 2020, Pathological findings in chronic inflammatory demyelinating polyradiculoneuropathy: a single-center experience, Brain Sci., 10, 10.3390/brainsci10060383
Luigetti, 2013, Inherited neuropathies and deafness caused by a PMP22 point mutation: a case report and a review of the literature, Neurol. Sci., 34, 1705, 10.1007/s10072-012-1277-5
Luo, 2019, A novel variant in non-coding region of GJB1 is associated with X-Linked charcot-marie-Tooth disease type 1 and transient CNS symptoms, Front. Neurol., 10, 413, 10.3389/fneur.2019.00413
Lupo, 2015, Complexity of the hereditary motor and sensory neuropathies: clinical and cellular characterization of the MPZ p.D90E mutation, J. Child Neurol., 30, 1544, 10.1177/0883073815571049
Lus, 2003, Charcot-Marie-Tooth disease with giant axons: a clinicopathological and genetic entity, Neurology, 61, 988, 10.1212/WNL.61.7.988
Madorsky, 2009, Intermittent fasting alleviates the neuropathic phenotype in a mouse model of Charcot-Marie-Tooth disease, Neurobiol. Dis., 34, 146, 10.1016/j.nbd.2009.01.002
Magot, 2008, A new MPZ mutation associated with a mild CMT1 phenotype presenting with recurrent nerve compression, Muscle Nerve, 38, 1055, 10.1002/mus.21050
Magyar, 1996, Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage, J. Neurosci., 16, 5351, 10.1523/JNEUROSCI.16-17-05351.1996
Mandich, 2009, Clinical features and molecular modelling of novel MPZ mutations in demyelinating and axonal neuropathies, Eur. J. Hum. Genet., 17, 1129, 10.1038/ejhg.2009.37
Mandich, 1999, Congenital hypomyelination due to myelin protein zero Q215X mutation, Ann. Neurol., 45, 676, 10.1002/1531-8249(199905)45:5<676::AID-ANA21>3.0.CO;2-K
Manganelli, 2016, Nerve conduction velocity in CMT1A: what else can we tell?, Eur. J. Neurol., 23, 1566, 10.1111/ene.13079
Manso, 2016, Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects, Brain, 139, 1700, 10.1093/brain/aww062
Marques, 2004, Dejerine-Sottas’ neuropathy caused by the missense mutation PMP22 Ser72Leu, Acta Neurol. Scand., 110, 196, 10.1111/j.1600-0404.2004.00295.x
Martini, 1995, Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies, Nat. Genet., 11, 281, 10.1038/ng1195-281
Mastaglia, 1999, Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy, J Neurol Neurosurg Psychiatry, 67, 174, 10.1136/jnnp.67.2.174
Mathey, 2015, Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype, J Neurol Neurosurg Psychiatry, 86, 973, 10.1136/jnnp-2014-309697
Mathis, 2014, Peripheral myelin protein 22 gene duplication with atypical presentations: a new example of the wide spectrum of Charcot-Marie-Tooth 1A disease, Neuromuscul. Disord., 24, 524, 10.1016/j.nmd.2014.03.014
Mazzeo, 2008, Charcot-Marie-Tooth type X: unusual phenotype of a novel CX32 mutation, Eur. J. Neurol., 15, 1140, 10.1111/j.1468-1331.2008.02263.x
Mazzeo, 2008, Charcot-Marie-Tooth disease type 1B: marked phenotypic variation of the Ser78Leu mutation in five Italian families, Acta Neurol. Scand., 118, 328, 10.1111/j.1600-0404.2008.01021.x
McKinney, 2014, Recurrent central nervous system white matter changes in charcot-Marie-tooth type X disease, Muscle Nerve, 49, 451, 10.1002/mus.24108
Meekins, 2007, Axonal degeneration in the Trembler-j mouse demonstrated by stimulated single-fiber electromyography, Muscle Nerve, 36, 81, 10.1002/mus.20786
Meekins, 2004, Nerve conduction abnormalities in the trembler-j mouse: a model for Charcot-Marie-Tooth disease type 1A?, J. Peripher. Nerv. Syst., 9, 177, 10.1111/j.1085-9489.2004.09310.x
Meggouh, 1998, The first de novo mutation of the connexin 32 gene associated with X linked Charcot-Marie-Tooth disease, J. Med. Genet., 35, 251, 10.1136/jmg.35.3.251
Meijerink, 1996, Clinically distinct codon 69 mutations in major myelin protein zero in demyelinating neuropathies, Ann. Neurol., 40, 672, 10.1002/ana.410400418
Mersiyanova, 2000, A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene, Am. J. Hum. Genet., 67, 37, 10.1086/302962
Meuleman, 2001, A novel 3’-splice site mutation in peripheral myelin protein 22 causing hereditary neuropathy with liability to pressure palsies, Neuromuscul. Disord., 11, 400, 10.1016/S0960-8966(00)00214-5
Michell, 2009, GJB1 gene mutations in suspected inflammatory demyelinating neuropathies not responding to treatment, J Neurol Neurosurg Psychiatry, 80, 699, 10.1136/jnnp.2008.150557
Miltenberger-Miltenyi, 2007, Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene, Arch. Neurol., 64, 966, 10.1001/archneur.64.7.966
Miltenberger-Miltenyi, 2009, Identification and in silico analysis of 14 novel GJB1, MPZ and PMP22 gene mutations, Eur. J. Hum. Genet., 17, 1154, 10.1038/ejhg.2009.29
Misu, 2000, An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val), J Neurol Neurosurg Psychiatry, 69, 806, 10.1136/jnnp.69.6.806
Moldovan, 2011, Na(v)1.8 channelopathy in mutant mice deficient for myelin protein zero is detrimental to motor axons, Brain, 134, 585, 10.1093/brain/awq336
Molloy, 2000, Maternal bilateral radial neuropathy during childbirth in hereditary neuropathy with a predisposition to pressure palsies (HNPP), J. Clin. Neuromuscul. Dis., 1, 131, 10.1097/00131402-200003000-00003
Montenegro, 2011, Exome sequencing allows for rapid gene identification in a Charcot-Marie-Tooth family, Ann. Neurol., 69, 464, 10.1002/ana.22235
Mori, 2016, Sonographic evaluation of peripheral nerves in subtypes of Guillain-Barre syndrome, J. Neurol. Sci., 364, 154, 10.1016/j.jns.2016.03.042
Moss, 2020, Targeting the programmed axon degeneration pathway as a potential therapeutic for Charcot-Marie-Tooth disease, Brain Res., 1727, 10.1016/j.brainres.2019.146539
Moszynska, 2009, A newly identified Thr99fsX110 mutation in the PMP22 gene associated with an atypical phenotype of the hereditary neuropathy with liability to pressure palsies, Acta Biochim. Pol., 56, 627, 10.18388/abp.2009_2494
Mouton, 1999, Spectrum of clinical and electrophysiologic features in HNPP patients with the 17p11.2 deletion, Neurology, 52, 1440, 10.1212/WNL.52.7.1440
Muller, 2003, Inflammatory infiltrates in the spinal cord of patients with Guillain-Barre syndrome, Acta Neuropathol., 106, 509, 10.1007/s00401-003-0768-0
Murakami, 2019, Schwann cell and the pathogenesis of charcot-marie-Tooth disease, Adv. Exp. Med. Biol., 1190, 301, 10.1007/978-981-32-9636-7_19
Murphy, 2011, A novel mutation in the nerve-specific 5’UTR of the GJB1 gene causes X-linked Charcot-Marie-Tooth disease, J. Peripher. Nerv. Syst., 16, 65, 10.1111/j.1529-8027.2011.00321.x
Murru, 2006, A novel Cx32 mutation causes X-linked Charcot-Marie-Tooth disease with brainstem involvement and brain magnetic resonance spectroscopy abnormalities, Neurol. Sci., 27, 18, 10.1007/s10072-006-0560-8
Nadal, 2000, Hereditary neuropathy with liability to pressure palsies: two cases with a reciprocal translocation t(16;17)(q12;11.2) interrupting the PMP22 gene, J. Med. Genet., 37, 396, 10.1136/jmg.37.5.396
Nagamatsu, 1999, Axonal and perikaryal involvement in chronic inflammatory demyelinating polyneuropathy, J Neurol Neurosurg Psychiatry, 66, 727, 10.1136/jnnp.66.6.727
Nakagawa, 2001, Clinical phenotype in X-linked Charcot-Marie-Tooth disease with an entire deletion of the connexin 32 coding sequence, J. Neurol. Sci., 185, 31, 10.1016/S0022-510X(01)00454-3
Nelis, 1997, C. van Broeckhoven, PMP22 Thr(118)Met: recessive CMT1 mutation or polymorphism?, Nat. Genet., 15, 13, 10.1038/ng0197-13
Neuberg, 1999, Altered molecular architecture of peripheral nerves in mice lacking the peripheral myelin protein 22 or connexin32, J. Neurosci. Res., 58, 612, 10.1002/(SICI)1097-4547(19991201)58:5<612::AID-JNR2>3.0.CO;2-X
Nicholson, 1991, Penetrance of the hereditary motor and sensory neuropathy Ia mutation: assessment by nerve conduction studies, Neurology, 41, 547, 10.1212/WNL.41.4.547
Nicholson, 1994, A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies, Nat. Genet., 6, 263, 10.1038/ng0394-263
Nobbio, 2009, Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy, J. Neuropathol. Exp. Neurol., 68, 441, 10.1097/NEN.0b013e31819fa6ba
Nobbio, 2006, Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease, Eur. J. Neurosci., 23, 1445, 10.1111/j.1460-9568.2006.04666.x
Nodera, 2004, Nerve excitability properties in Charcot-Marie-Tooth disease type 1A, Brain, 127, 203, 10.1093/brain/awh020
Numakura, 2000, Hemizygous mutation of the peripheral myelin protein 22 gene associated with Charcot-Marie-Tooth disease type 1, Ann. Neurol., 47, 101, 10.1002/1531-8249(200001)47:1<101::AID-ANA16>3.0.CO;2-2
O’Connor, 2012, Late-onset CMT phenotype caused by a novel mutation in the MPZ gene, Eur. J. Neurol., 19, e65, 10.1111/j.1468-1331.2012.03727.x
Ogata, 2015, Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy, Ann. Clin. Transl. Neurol., 2, 960, 10.1002/acn3.248
Ohkoshi, 2001, Acute vocal cord paralysis in hereditary neuropathy with liability to pressure palsies, Neurology, 56, 1415, 10.1212/WNL.56.10.1415
Ohyama, 2014, Muscle atrophy in chronic inflammatory demyelinating polyneuropathy: a computed tomography assessment, Eur. J. Neurol., 21, 1002, 10.1111/ene.12426
Oka, 2013, Different profiles of onion bulb in CIDP and CMT1A in relation to extracellular matrix, Clin. Neuropathol., 32, 406, 10.5414/NP300597
Ong, 2019, A severe form of m - protein negative distal acquired demyelinating symmetric neuropathy, Neurol. India, 67, 1532, 10.4103/0028-3886.273621
Orstavik, 2001, Brachial plexus involvement as the only expression of hereditary neuropathy with liability to pressure palsies, Muscle Nerve, 24, 1093, 10.1002/mus.1116
Osterlund-Tauriala, 2017, Three cases of acute distal demyelinating neuropathy with recovery, Clin. Case Rep., 5, 822, 10.1002/ccr3.943
Oterino, 1996, Arginine-164-tryptophan substitution in connexin32 associated with X linked dominant Charcot-Marie-Tooth disease, J. Med. Genet., 33, 413, 10.1136/jmg.33.5.413
Ozel, 2018, Hereditary neuropathy with liability to pressure palsies mimicking chronic inflammatory demyelinating polyneuropathy, Rev Neurol (Paris), 174, 575, 10.1016/j.neurol.2017.11.012
Pan, 2017, Regulation and dysregulation of axon infrastructure by myelinating glia, J. Cell Biol., 216, 3903, 10.1083/jcb.201702150
Panosyan, 2017, N. Inherited Neuropathies Consortium-rare Diseases Clinical Research, cross-sectional analysis of a large cohort with X-linked charcot-marie-Tooth disease (CMTX1), Neurology, 89, 927, 10.1212/WNL.0000000000004296
Pantera, 2020, Pmp22 super-enhancer deletion causes tomacula formation and conduction block in peripheral nerves, Hum. Mol. Genet., 29, 1689, 10.1093/hmg/ddaa082
Paramanathan, 2016, Axonal loss in patients with inflammatory demyelinating polyneuropathy as determined by motor unit number estimation and MUNIX, Clin. Neurophysiol., 127, 898, 10.1016/j.clinph.2015.05.004
Pareyson, 1999, Heterozygous null mutation in the P0 gene associated with mild Charcot-Marie-Tooth disease, Ann. N. Y. Acad. Sci., 883, 477, 10.1111/j.1749-6632.1999.tb08615.x
Pareyson, 2000, Cranial nerve involvement in CMT disease type 1 due to early growth response 2 gene mutation, Neurology, 54, 1696, 10.1212/WNL.54.8.1696
Park, 2016, Compression of root level in a patient with hereditary neuropathy with liability to pressure palsy diagnosed by magnetic resonance imaging, Am. J. Phys. Med. Rehabil., 95, e140, 10.1097/PHM.0000000000000515
Park, 2006, Mutation analysis of the PMP22, MPZ, EGR2, LITAF, and GJB1 genes in Korean patients with Charcot-Marie-Tooth neuropathy type 1, Clin. Genet., 70, 253, 10.1111/j.1399-0004.2006.00669.x
Pereira, 2010, Dicer in Schwann cells is required for myelination and axonal integrity, J. Neurosci., 30, 6763, 10.1523/JNEUROSCI.0801-10.2010
Perez-Olle, 2004, Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models, Hum. Mol. Genet., 13, 2207, 10.1093/hmg/ddh236
Perrot, 2007, Axonal neurofilaments control multiple fiber properties but do not influence structure or spacing of nodes of Ranvier, J. Neurosci., 27, 9573, 10.1523/JNEUROSCI.1224-07.2007
Perugula, 2017, Acute demyelinating polyneuropathy as presentation of hereditary neuropathy with liability to pressure palsies in a patient who exercised regularly in the army, J. Clin. Neuromuscul. Dis., 18, 228, 10.1097/CND.0000000000000145
Piazza, 2010, A new truncating MPZ mutation associated with a very mild CMT1 B phenotype, Neuromuscul. Disord., 20, 817, 10.1016/j.nmd.2010.08.003
Pillai, 2009, Spatiotemporal ablation of myelinating glia-specific neurofascin (Nfasc NF155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains, J. Neurosci. Res., 87, 1773, 10.1002/jnr.22015
Pisciotta, 2015, Reduced neurofilament expression in cutaneous nerve fibers of patients with CMT2E, Neurology, 85, 228, 10.1212/WNL.0000000000001773
Pisciotta, 2011, Thermosensitive hereditary neuropathy with liability to pressure palsy, Muscle Nerve, 43, 448, 10.1002/mus.21921
Pisciotta, 2009, Two families with novel PMP22 point mutations: genotype-phenotype correlation, J. Peripher. Nerv. Syst., 14, 208, 10.1111/j.1529-8027.2009.00235.x
Pollard, 1980, Nerve grafts in the Trembler mouse. An electrophysiological and histological study, J. Neurol. Sci., 46, 373, 10.1016/0022-510X(80)90062-3
Porter, 2009, Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X, Pediatr. Blood Cancer, 52, 298, 10.1002/pbc.21786
Potulska-Chromik, 2016, Are electrophysiological criteria useful in distinguishing childhood demyelinating neuropathies?, J. Peripher. Nerv. Syst., 21, 22, 10.1111/jns.12152
Pridmore, 2020, Length-dependent MRI of hereditary neuropathy with liability to pressure palsies, Ann. Clin. Transl. Neurol., 7, 15, 10.1002/acn3.50953
Querol, 2013, Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy, Ann. Neurol., 73, 370, 10.1002/ana.23794
Querol, 2015, Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins, Neurol. Neuroimmunol. Neuroinflamm., 2, e149, 10.1212/NXI.0000000000000149
Rajabally, 2011, Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathy, Eur. J. Neurol., 18, 293, 10.1111/j.1468-1331.2010.03138.x
Reisecker, 1994, A sporadic form of hereditary neuropathy with liability to pressure palsies: clinical, electrodiagnostic, and molecular genetic findings, Neurology, 44, 753, 10.1212/WNL.44.4.753
Reyes-Marin, 2011, A novel myelin protein zero (V136G) homozygous mutation causing late onset demyelinating polyneuropathy with brain white matter lesions, Clin. Neurol. Neurosurg., 113, 243, 10.1016/j.clineuro.2010.10.015
Rieger, 1986, Neuronal cell adhesion molecules and cytotactin are colocalized at the node of Ranvier, J. Cell Biol., 103, 379, 10.1083/jcb.103.2.379
Rizzuto, 1998, Focal lesions area feature of chronic inflammatory demyelinating polyneuropathy (CIDP), Acta Neuropathol., 96, 603, 10.1007/s004010050941
Robertson, 1997, Abnormal Schwann cell/axon interactions in the Trembler-J mouse, J. Anat., 190, 423, 10.1046/j.1469-7580.1997.19030423.x
Robertson, 2002, Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A, J. Anat., 200, 377, 10.1046/j.1469-7580.2002.00039.x
Rosenbluth, 2009, Multiple functions of the paranodal junction of myelinated nerve fibers, J. Neurosci. Res., 87, 3250, 10.1002/jnr.22013
Rosenbluth, 2014, Paranodal dysmyelination in peripheral nerves of Trembler mice, J. Neurosci. Res., 92, 476, 10.1002/jnr.23326
Rostami, 1984, The role of myelin P2 protein in the production of experimental allergic neuritis, Ann. Neurol., 16, 680, 10.1002/ana.410160610
Russo, 2011, Variable phenotypes are associated with PMP22 missense mutations, Neuromuscul. Disord., 21, 106, 10.1016/j.nmd.2010.11.011
Ryan, 2005, CMTX mimicking childhood chronic inflammatory demyelinating neuropathy with tremor, Muscle Nerve, 31, 528, 10.1002/mus.20292
Sabet, 2006, Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B, Neurology, 67, 1141, 10.1212/01.wnl.0000238499.37764.b1
Safka Brozkova, 2012, Charcot-Marie-Tooth neuropathy due to a novel EGR2 gene mutation with mild phenotype--usefulness of human mapping chip linkage analysis in a Czech family, Neuromuscul. Disord., 22, 742, 10.1016/j.nmd.2012.04.002
Sagnelli, 2014, X-linked Charcot-Marie-Tooth type 1: stroke-like presentation of a novel GJB1 mutation, J. Peripher. Nerv. Syst., 19, 183, 10.1111/jns5.12070
Sahenk, 1999, Abnormal schwann cell-axon interactions in CMT neuropathies: the effects of mutant schwann cells on the axonal cytoskeleton and regeneration-associated myelination, Ann. N. Y. Acad. Sci., 883, 415, 10.1111/j.1749-6632.1999.tb08602.x
Sahenk, 1998, Abnormalities in the axonal cytoskeleton induced by a connexin32 mutation in nerve xenografts, J. Neurosci. Res., 51, 174, 10.1002/(SICI)1097-4547(19980115)51:2<174::AID-JNR6>3.0.CO;2-A
Sahenk, 1998, A novel PMP22 point mutation causing HNPP phenotype: studies on nerve xenografts, Neurology, 51, 702, 10.1212/WNL.51.3.702
Sahenk, 1999, Effects of PMP22 duplication and deletions on the axonal cytoskeleton, Ann. Neurol., 45, 16, 10.1002/1531-8249(199901)45:1<16::AID-ART5>3.0.CO;2-F
Sahenk, 2005, NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients, Neurology, 65, 681, 10.1212/01.WNL.0000171978.70849.c5
Saifi, 2005, SIMPLE mutations in Charcot-Marie-Tooth disease and the potential role of its protein product in protein degradation, Hum. Mutat., 25, 372, 10.1002/humu.20153
Salomon, 2001, Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice, J. Exp. Med., 194, 677, 10.1084/jem.194.5.677
Sambuughin, 2003, Deafness and CMT disease associated with a novel four amino acid deletion in the PMP22 gene, Neurology, 60, 506, 10.1212/01.WNL.0000044048.27971.FC
Sancho, 1999, Distal axonopathy in peripheral nerves of PMP22-mutant mice, Brain, 122, 1563, 10.1093/brain/122.8.1563
Sander, 1998, Charcot-Marie-Tooth disease: histopathological features of the peripheral myelin protein (PMP22) duplication (CMT1A) and connexin32 mutations (CMTX1), Muscle Nerve, 21, 217, 10.1002/(SICI)1097-4598(199802)21:2<217::AID-MUS9>3.0.CO;2-E
Sanmaneechai, 2015, C. Inherited Neuropathies Consortium - Rare Disease Clinical Research, Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene, Brain, 138, 3180, 10.1093/brain/awv241
Saporta, 2012, MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B, Brain, 135, 2032, 10.1093/brain/aws140
Scelsa, 2010, Familial, demyelinating sensory and motor polyneuropathy with conduction block, Muscle Nerve, 41, 558, 10.1002/mus.21558
Scherer, 1998, Connexin32-null mice develop demyelinating peripheral neuropathy, Glia, 24, 8, 10.1002/(SICI)1098-1136(199809)24:1<8::AID-GLIA2>3.0.CO;2-3
Schneider-Gold, 2010, Unusual Charcot-Marie-Tooth phenotype due to a mutation within the intracellular domain of myelin protein zero, Muscle Nerve, 41, 550, 10.1002/mus.21523
Schreiber, 2013, Sonography of the median nerve in CMT1A, CMT2A, CMTX, and HNPP, Muscle Nerve, 47, 385, 10.1002/mus.23681
Senderek, 1999, X-linked dominant Charcot-Marie-Tooth neuropathy: clinical, electrophysiological, and morphological phenotype in four families with different connexin32 mutations(1), J. Neurol. Sci., 167, 90, 10.1016/S0022-510X(99)00146-X
Senderek, 2000, Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations: two novel amino acid substitutions (Asp61Gly; Tyr119Cys) and a possible "hotspot" on Thr124Met, Brain Pathol., 10, 235, 10.1111/j.1750-3639.2000.tb00257.x
Sereda, 1996, A transgenic rat model of Charcot-Marie-Tooth disease, Neuron, 16, 1049, 10.1016/S0896-6273(00)80128-2
Sessa, 1997, Atypical hereditary neuropathy with liability to pressure palsies (HNPP): the value of direct DNA diagnosis, J. Med. Genet., 34, 889, 10.1136/jmg.34.11.889
Sevilla, 2011, Congenital hypomyelinating neuropathy due to a novel MPZ mutation, J. Peripher. Nerv. Syst., 16, 347, 10.1111/j.1529-8027.2011.00369.x
Sevilla, 2015, The EGR2 gene is involved in axonal Charcot-Marie-Tooth disease, Eur. J. Neurol., 22, 1548, 10.1111/ene.12782
Shahrizaila, 2011, Serial nerve conduction studies provide insight into the pathophysiology of Guillain-Barre and Fisher syndromes, J. Neurol. Sci., 309, 26, 10.1016/j.jns.2011.07.042
Shaibani, 1997, Moving toes and myoclonus associated with hereditary neuropathy with liability to pressure palsy (HNPP), Muscle Nerve, 20, 881, 10.1002/(SICI)1097-4598(199707)20:7<881::AID-MUS13>3.0.CO;2-V
Shibuya, 2019, Hidden charcot-marie-Tooth 1A as revealed by peripheral nerve imaging, Intern. Med., 58, 3157, 10.2169/internalmedicine.3040-19
Shiga, 2012, A novel EGR2 mutation within a family with a mild demyelinating form of Charcot-Marie-Tooth disease, J. Peripher. Nerv. Syst., 17, 206, 10.1111/j.1529-8027.2012.00403.x
Shimizu, 2010, Late-onset CMT2 associated with a novel missense mutation in the cytoplasmic domain of the MPZ gene, Clin. Neurol. Neurosurg., 112, 798, 10.1016/j.clineuro.2010.07.020
Shin, 2008, NEFL Pro22Arg mutation in Charcot-Marie-Tooth disease type 1, J. Hum. Genet., 53, 936, 10.1007/s10038-008-0333-8
Shu, 2015, X-linked hereditary motor sensory neuropathy type 1 (CMTX1) in a three-generation gelao chinese family, Neuropediatrics, 46, 424, 10.1055/s-0035-1564619
Shy, 2008, Neuropathy progression in Charcot-Marie-Tooth disease type 1A, Neurology, 70, 378, 10.1212/01.wnl.0000297553.36441.ce
Shy, 2006, T118M PMP22 mutation causes partial loss of function and HNPP-like neuropathy, Ann. Neurol., 59, 358, 10.1002/ana.20777
Shy, 2007, CMT1X phenotypes represent loss of GJB1 gene function, Neurology, 68, 849, 10.1212/01.wnl.0000256709.08271.4d
Simonetti, 2000, Lesion of the anterior branch of axillary nerve in a patient with hereditary neuropathy with liability to pressure palsies, Eur. J. Neurol., 7, 577, 10.1046/j.1468-1331.2000.t01-1-00121.x
Simpson, 2010, Charcot-Marie-Tooth disease due to novel myelin protein zero mutation presenting as late-onset remitting sensory neuropathy, J. Clin. Neuromuscul. Dis., 11, 187, 10.1097/CND.0b013e3181a84bb8
Sindern, 2001, Inflammatory polyradiculoneuropathy with spinal cord involvement and lethal [correction of letal] outcome after hepatitis B vaccination, J. Neurol. Sci., 186, 81, 10.1016/S0022-510X(01)00510-X
Siskind, 2009, Persistent CNS dysfunction in a boy with CMT1X, J. Neurol. Sci., 279, 109, 10.1016/j.jns.2008.12.031
Sotelo, 2013, Myosin-Va-dependent cell-to-cell transfer of RNA from Schwann cells to axons, PLoS One, 8, 10.1371/journal.pone.0061905
Souayah, 2007, Rare myelin protein zero sequence variant in late onset CMT1B, J. Neurol. Sci., 263, 177, 10.1016/j.jns.2007.05.020
Souayah, 2010, Asymmetric phenotype associated with rare myelin protein zero mutation, J. Clin. Neuromuscul. Dis., 11, 110, 10.1097/CND.0b013e3181c5058a
Sowden, 2005, Genotype-phenotype correlation in a family with late onset CMT and an MPZ lys236del mutation, J Neurol Neurosurg Psychiatry, 76, 442, 10.1136/jnnp.2004.043968
Stancanelli, 2012, Unusual features of central nervous system involvement in CMTX associated with a novel mutation of GJB1 gene, J. Peripher. Nerv. Syst., 17, 407, 10.1111/j.1529-8027.2012.00439.x
Starr, 2003, Pathology and physiology of auditory neuropathy with a novel mutation in the MPZ gene (Tyr145-&Ser), Brain, 126, 1604, 10.1093/brain/awg156
Starr, 1996, Neurofilament phosphorylation is modulated by myelination, J. Neurosci. Res., 44, 328, 10.1002/(SICI)1097-4547(19960515)44:4<328::AID-JNR3>3.0.CO;2-E
Stiefel, 2013, Proposed evolutionary changes in the role of myelin, Front. Neurosci., 7, 202, 10.3389/fnins.2013.00202
Stojkovic, 2003, Autonomic and respiratory dysfunction in Charcot-Marie-Tooth disease due to Thr124Met mutation in the myelin protein zero gene, Clin. Neurophysiol., 114, 1609, 10.1016/S1388-2457(03)00159-7
Stojkovic, 1999, Sensorineural deafness in X-linked Charcot-Marie-Tooth disease with connexin 32 mutation (R142Q), Neurology, 52, 1010, 10.1212/WNL.52.5.1010
Stoll, 2015, Severe acute inflammatory demyelinating polyradiculoneuropathy with persistent weakness associated with tumor-like nerve root enlargement, J. Clin. Neuromuscul. Dis., 16, 220, 10.1097/CND.0000000000000076
Sun, 2016, Mutation analysis of gap junction protein Beta 1 and genotype-phenotype correlation in X-linked charcot-marie-Tooth disease in chinese patients, Chin Med J (Engl), 129, 1011, 10.4103/0366-6999.180511
Sun, 2019, A novel p.Va137A1a mutation in the GJB1 gene of a Chinese family with X-linked recessive Charcot-Marie-Tooth disease: a case report and literature review, Int. J. Clin. Exp. Med., 12, 11880
Szigeti, 2003, Disturbance of muscle fiber differentiation in congenital hypomyelinating neuropathy caused by a novel myelin protein zero mutation, Ann. Neurol., 54, 398, 10.1002/ana.10681
Taioli, 2012, Parental mosaicism of a novel PMP22 mutation with a minimal neuropathic phenotype, J. Peripher. Nerv. Syst., 17, 414, 10.1111/j.1529-8027.2012.00441.x
Taioli, 2011, Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene, Brain, 134, 608, 10.1093/brain/awq374
Taioli, 2011, Dejerine-Sottas syndrome with a silent nucleotide change of myelin protein zero gene, J. Peripher. Nerv. Syst., 16, 59, 10.1111/j.1529-8027.2011.00319.x
Takashima, 2003, Gap junction protein beta 1 (GJB1) mutations and central nervous system symptoms in X-linked Charcot-Marie-Tooth disease, Acta Neurol. Scand., 107, 31, 10.1034/j.1600-0404.2003.01317.x
Thiex, 1998, PMP-22 gene duplications and deletions identified in archival, paraffin-embedded sural nerve biopsy specimens: correlation to structural changes, Acta Neuropathol., 96, 13, 10.1007/s004010050855
Thomas, 1997, The phenotypic manifestations of chromosome 17p11.2 duplication, Brain, 120, 465, 10.1093/brain/120.3.465
Timmerman, 1999, Novel missense mutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype, Neurology, 52, 1827, 10.1212/WNL.52.9.1827
Tokuda, 2015, Parasympathetic dominant autonomic dysfunction in charcot-marie-Tooth disease type 2J with the MPZ Thr124Met mutation, Intern. Med., 54, 1919, 10.2169/internalmedicine.54.4259
Tomaselli, 2017, Mutations in noncoding regions of GJB1 are a major cause of X-linked CMT, Neurology, 88, 1445, 10.1212/WNL.0000000000003819
Topakian, 2014, Hereditary neuropathy with liability to pressure palsies presenting with sciatic neuropathy, BMJ Case Rep., 2014, 10.1136/bcr-2014-206883
Tozza, 2019, A novel family with axonal Charcot-Marie-Tooth disease caused by a mutation in the EGR2 gene, J. Peripher. Nerv. Syst., 24, 219, 10.1111/jns.12314
Tricaud, 2017, Myelinating schwann cell polarity and mechanically-driven myelin sheath elongation, Front. Cell. Neurosci., 11, 414, 10.3389/fncel.2017.00414
Triggs, 2006, Case records of the Massachusetts General Hospital. Case 18-2006. A 57-year-old woman with numbness and weakness of the feet and legs, N. Engl. J. Med., 354, 2584, 10.1056/NEJMcpc069009
Tsai, 2016, Clinical and biophysical characterization of 19 GJB1 mutations, Ann. Clin. Transl. Neurol., 3, 854, 10.1002/acn3.347
Tyson, 1996, Deletions of chromosome 17p11.2 in multifocal neuropathies, Ann. Neurol., 39, 180, 10.1002/ana.410390207
Ubogu, 2012, Behavioral, electrophysiological, and histopathological characterization of a severe murine chronic demyelinating polyneuritis model, J. Peripher. Nerv. Syst., 17, 53, 10.1111/j.1529-8027.2012.00375.x
Umehara, 2006, New mutation of gap junction protein beta1 (GJB1) gene in X-linked hereditary motor and sensory neuropathy, J. Peripher. Nerv. Syst., 11, 96, 10.1111/j.1085-9489.2006.00072.x
Uncini, 1995, Differential electrophysiological features of neuropathies associated with 17p11.2 deletion and duplication, Muscle Nerve, 18, 628, 10.1002/mus.880180610
Uncini, 2010, Pitfalls in electrodiagnosis of Guillain-Barre syndrome subtypes, J Neurol Neurosurg Psychiatry, 81, 1157, 10.1136/jnnp.2010.208538
Vallat, 2020, Antibody- and macrophage-mediated segmental demyelination in chronic inflammatory demyelinating polyneuropathy: clinical, electrophysiological, immunological and pathological correlates, Eur. J. Neurol., 27, 692, 10.1111/ene.14133
Vallat, 1996, Ultrastructural PMP22 expression in inherited demyelinating neuropathies, Ann. Neurol., 39, 813, 10.1002/ana.410390621
Vallat, 2003, Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases, Muscle Nerve, 27, 478, 10.1002/mus.10348
van den Berg, 2014, Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis, Nat. Rev. Neurol., 10, 469, 10.1038/nrneurol.2014.121
Vavlitou, 2010, Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy, J. Neuropathol. Exp. Neurol., 69, 945, 10.1097/NEN.0b013e3181efa658
Vazza, 2006, A novel 9-bp insertion in the GJB1 gene causing a mild form of X-linked CMT with late onset, Neuromuscul. Disord., 16, 878, 10.1016/j.nmd.2006.09.002
Verhalle, 1994, Deletion in the CMT1A locus on chromosome 17p11.2 in hereditary neuropathy with liability to pressure palsies, Ann. Neurol., 35, 704, 10.1002/ana.410350611
Verhamme, 2011, Myelin and axon pathology in a long-term study of PMP22-overexpressing mice, J. Neuropathol. Exp. Neurol., 70, 386, 10.1097/NEN.0b013e318217eba0
Viader, 2011, Schwann cell mitochondrial metabolism supports long-term axonal survival and peripheral nerve function, J. Neurosci., 31, 10128, 10.1523/JNEUROSCI.0884-11.2011
Videler, 2008, Motor axon loss is associated with hand dysfunction in Charcot-Marie-Tooth disease 1a, Neurology, 71, 1254, 10.1212/01.wnl.0000327643.05073.eb
Vigo, 2005, Experimental Charcot-Marie-Tooth type 1A: a cDNA microarrays analysis, Mol. Cell. Neurosci., 28, 703, 10.1016/j.mcn.2004.11.016
Villalon, 2017, Muscle spindle alterations precede onset of sensorimotor deficits in Charcot-Marie-Tooth type 2E, Genes Brain Behav., 16, 260, 10.1111/gbb.12341
Vital, 2001, Histopathological features of X-linked Charcot-Marie-Tooth disease in 8 patients from 6 families with different connexin32 mutations, J. Peripher. Nerv. Syst., 6, 79, 10.1046/j.1529-8027.2001.01011.x
Vital, 2000, Chronic inflammatory demyelinating polyneuropathy associated with dysglobulinemia: a peripheral nerve biopsy study in 18 cases, Acta Neuropathol., 100, 63, 10.1007/s004010051193
Vital, 2003, Inflammatory demyelination in a patient with CMT1A, Muscle Nerve, 28, 373, 10.1002/mus.10404
Vital, 2004, Peripheral nerve biopsy study in 19 cases with 17p11.2 deletion, J. Neuropathol. Exp. Neurol., 63, 1167, 10.1093/jnen/63.11.1167
Vital, 2000, Chronic inflammatory demyelinating polyneuropathy: immunopathological and ultrastructural study of peripheral nerve biopsy in 42 cases, Ultrastruct. Pathol., 24, 363, 10.1080/019131200750060023
Vondracek, 2005, X-linked Charcot-Marie-Tooth disease: phenotypic expression of a novel mutation Ile127Ser in the GJB1 (connexin 32) gene, Muscle Nerve, 31, 252, 10.1002/mus.20166
Vrancken, 2010, X-linked Charcot-Marie-Tooth disease with novel c.47A&T GJB1 gene mutation, J. Peripher. Nerv. Syst., 15, 156, 10.1111/j.1529-8027.2010.00266.x
Wali, 2017, Early electrophysiological findings in acute inflammatory demyelinating polyradiculoneuropathy variant of Guillain-Barre syndrome in the Pakistani population - a comparison with global data, J. Peripher. Nerv. Syst., 22, 451, 10.1111/jns.12241
Wang, 2017, PMP22 exon 4 deletion causes ER retention of PMP22 and a gain-of-function allele in CMT1E, Ann. Clin. Transl. Neurol., 4, 236, 10.1002/acn3.395
Wang, 1995, Hypomyelination alters K+ channel expression in mouse mutants shiverer and Trembler, Neuron, 15, 1337, 10.1016/0896-6273(95)90012-8
Wang, 2016, Target-enrichment sequencing and copy number evaluation in inherited polyneuropathy, Neurology, 86, 1762, 10.1212/WNL.0000000000002659
Warner, 1996, Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination, Neuron, 17, 451, 10.1016/S0896-6273(00)80177-4
Warner, 1998, Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies, Nat. Genet., 18, 382, 10.1038/ng0498-382
Wedderburn, 2014, Hereditary neuropathy with liability to pressure palsy presenting as an acute brachial plexopathy: a lover’s palsy, Case Rep. Neurol., 6, 281, 10.1159/000369921
Wen, 2018, The electrophysiological features in X-Linked charcot-marie-Tooth disease with transient central nervous system deficits, Front. Neurol., 9, 461, 10.3389/fneur.2018.00461
Wicklein, 1997, Missense mutation (R15W) of the connexin32 gene in a family with X chromosomal Charcot-Marie-Tooth neuropathy with only female family members affected, J Neurol Neurosurg Psychiatry, 63, 379, 10.1136/jnnp.63.3.379
Wong, 2018, Davidenkow syndrome: a phenotypic variant of hereditary neuropathy with liability to pressure palsies, Muscle Nerve, 57, E108, 10.1002/mus.25985
Wrabetz, 2006, Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice, J. Neurosci., 26, 2358, 10.1523/JNEUROSCI.3819-05.2006
Wrabetz, 2000, P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves, J. Cell Biol., 148, 1021, 10.1083/jcb.148.5.1021
Wu, 2015, Recurrent episodes of stroke-like symptoms in a patient with charcot-marie-Tooth neuropathy X type 1, Case Rep. Neurol., 7, 247, 10.1159/000442410
Wu, 2019, Homozygous splice-site mutation c.78 + 5G&A in PMP22 causes congenital hypomyelinating neuropathy, Neuropathology, 39, 441, 10.1111/neup.12604
Wu, 2017, Clinical and pathological variation of charcot-marie-Tooth 1A in a large chinese cohort, Biomed Res. Int., 2017, 10.1155/2017/6481367
Xia, 2010, Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barre syndrome, J. Neuroimmunol., 219, 54, 10.1016/j.jneuroim.2009.11.019
Xiao, 2015, A novel mutation in GJB1 (c.212T&G) in a Chinese family with X-linked Charcot-Marie-Tooth disease, J. Clin. Neurosci., 22, 513, 10.1016/j.jocn.2014.08.028
Xu, 2013, Actin, spectrin, and associated proteins form a periodic cytoskeletal structure in axons, Science, 339, 452, 10.1126/science.1232251
Yang, 2016, N98S mutation in NEFL gene is dominantly inherited with a phenotype of polyneuropathy and cerebellar atrophy, J. Neurol. Sci., 365, 46, 10.1016/j.jns.2016.04.007
Yilmaz, 2015, Pain in hereditary neuropathy with liability to pressure palsy: an association with fibromyalgia syndrome?, Muscle Nerve, 51, 385, 10.1002/mus.24331
Yin, 1998, Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons, J. Neurosci., 18, 1953, 10.1523/JNEUROSCI.18-06-01953.1998
Yiu, 2008, Neurophysiologic abnormalities in children with Charcot-Marie-Tooth disease type 1A, J. Peripher. Nerv. Syst., 13, 236, 10.1111/j.1529-8027.2008.00182.x
Yoshihara, 2000, Mutations in the peripheral myelin protein zero and connexin32 genes detected by non-isotopic RNase cleavage assay and their phenotypes in Japanese patients with Charcot-Marie-Tooth disease, Hum. Mutat., 16, 177, 10.1002/1098-1004(200008)16:2<177::AID-HUMU14>3.0.CO;2-5
Yoshihara, 2002, Identification of novel sequence variants in the neurofilament-light gene in a Japanese population: analysis of Charcot-Marie-Tooth disease patients and normal individuals, J. Peripher. Nerv. Syst., 7, 221, 10.1046/j.1529-8027.2002.02028.x
Young, 2000, PMP22 Thr118Met is not a clinically relevant CMT1 marker, J. Neurol., 247, 696, 10.1007/s004150070113
Yum, 2009, A novel recessive Nefl mutation causes a severe, early-onset axonal neuropathy, Ann. Neurol., 66, 759, 10.1002/ana.21728
Yurrebaso, 2014, Clinical, electrophysiological and magnetic resonance findings in a family with hereditary neuropathy with liability to pressure palsies caused by a novel PMP22 mutation, Neuromuscul. Disord., 24, 56, 10.1016/j.nmd.2013.09.005
Zambon, 2020, A novel homozygous variant extending the peripheral myelin protein 22 by 9 amino acids causes early-onset Charcot-Marie-Tooth disease with predominant severe sensory ataxia, J. Peripher. Nerv. Syst., 10.1111/jns.12386
Zanette, 2019, Nerve size correlates with clinical severity in Charcot-Marie-Tooth disease 1A, Muscle Nerve, 60, 744, 10.1002/mus.26688
Zephir, 2005, A family with a novel frameshift mutation in the PMP22 gene (c.433_434insC) causing a phenotype of hereditary neuropathy with liability to pressure palsies, Neuromuscul. Disord., 15, 493, 10.1016/j.nmd.2005.04.007
Zielasek, 1999, Nerve conduction abnormalities and neuromyotonia in genetically engineered mouse models of human hereditary neuropathies, Ann. N. Y. Acad. Sci., 883, 310, 10.1111/j.1749-6632.1999.tb08593.x